Stay updated with breaking news from Betsyp Leitch. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Autosomal dominant polycystic kidney disease (ADPKD), the most common form of polycystic kidney disease, can lead to kidney enlargement and eventual loss of function.
A compound originally developed as a cancer treatment may hold promise for treating polycystic kidney disease (ADPKD), which affects more than half a million Americans and can lead to kidney enlargement and loss of function.
ADPKD, the prevalent form of polycystic kidney disease, causes kidney enlargement, often leading to function loss.
ADPKD, the prevalent form of polycystic kidney disease, causes kidney enlargement, often leading to function loss.